[Anti-TNF agents in inflammatory bowel disease: indications and management].
Cocq
Perrine
P
Hépato-Gastroentérologie, Centre Hospitalier, 59200 Tourcoing.
Yazdanpannah
Yazdan
Y
Mesnard
Bruno
B
Colombel
Jean-Frédéric
JF
D000465:Algorithms; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab